Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi‐eligible countries

The human papillomavirus (HPV) vaccines may provide some level of cross‐protection against high‐risk HPV genotypes not directly targeted by the vaccines. We evaluated the long‐term health and economic impacts of routine HPV vaccination using either the nonavalent HPV vaccine or the bivalent HPV vacc...

Full description

Saved in:

Bibliographic Details
Published in:	International journal of cancer Vol. 148; no. 4; pp. 932 - 940
Main Authors:	Burger, Emily A., Portnoy, Allison, Campos, Nicole G., Sy, Stephen, Regan, Catherine, Kim, Jane J.
Format:	Journal Article
Language:	English
Published:	Hoboken, USA John Wiley & Sons, Inc 15.02.2021 Wiley Subscription Services, Inc
Subjects:	Cancer Cancer vaccines Cervical cancer Cervix GDP Genotypes Gross Domestic Product Human papillomavirus Immunization low‐ and middle‐income countries Medical research Vaccines low- and middle-income countries vaccines cervical cancer human papillomavirus
ISSN:	0020-7136, 1097-0215, 1097-0215
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!